[1]
İlyas Öztürk, “Response to the Letter to the Editor Entitled ‘What’s Missing in Diabetes Treatment? A Novel Agent, Finerenone?’”, J Eur Int Med Prof, vol. 4, no. 1, pp. 43–43, Feb. 2026.